Company: APXIF
Filing Date: 2025-06-13
Form Type: F-4/A
Source: 0001213900-25-054324
Chunk: 381

Company: APx Acquisition Corp. I
Filing Date: 2025-06-13
Form: F-4/A
Chunk 381
---
, microbiome, or saliva sample, and process it utilizing Ilumina® Next Generation Sequencing equipment that allows complete genome sequencing. Once processed, advanced bioinformatics are applied to interpret complex genetic data and generate results. Rewell’s results are automatically generated and presented within the Rewell platform, while Heritas Diagnostics utilizes a team of medical geneticists to write reports that are signed by our biochemist to certify the results provided to physicians and/or patients. Our Argentine Wet -Labis certified with ISO 9001 quality standards, alongside external quality control procedures by EMQN/CAP, to provide the highest testing quality. Operating a laboratory allows us to generate synergies by vertically integrating the supply chain for both Rewell and Heritas Diagnostic, enabling us to manage costs, production, inventory, distribution, and product quality. Competition Our competitors include companies that offer genetic testing, screening and consulting services in the medical and consumer space, including specialty and reference laboratories that offer traditional single- and multi -genetests. Principal direct and indirect competitors include companies such as Synlab; Centogene N.V.; Invitae Corporation; Mendelics Análise Genômica S.A., Diagnósticos da América S.A.; Igenomix S.L.; Nimgenetics Genómica Y Medicina, S.L.; Color Health, Inc.; Bitgenia Brasil Ltda.; Biomakers S.A.; Argenetics Semillas S.A.; Argenomics S.A.; Genda S.A.; Genos S.A.; Biocodices S.A.; Diagnóstico Maipú por Imágenes S.A.; Viome Life Sciences, Inc; Zoe Limited; 23andMe, Inc.; Ambry Genetics Corporation, a subsidiary of Realm IDx, Inc.; Athena Diagnostics, Inc. and Blueprint Genetics, subsidiaries of Quest Diagnostics Incorporated; Baylor -MiracaGenetics Laboratories LLC; Centogene AG; Connective Tissue Gene Test LLC, a subsidiary of Health Network Laboratories, L.P.; Cooper Surgical, Inc.; Emory Genetics Laboratory, a subsidiary of Eurofins Scientific; Exact Sciences Corporation; Foundation Medicine, Inc., a subsidiary of Roche Holding AG; Freenome Holding, Inc.; Fulgent Genetics, Inc.; GeneDx Holdings Corp; Guardant Health, Inc.; Integrated Genetics, Sequenom Inc., Correlagen Diagnostics, Inc., and MNG Laboratories, subsidiaries of Laboratory Corporation of America Holdings; Myriad Genetics, Inc.; Natera, Inc.; Tempus Labs,